Objective: To determine the association between serum
phosphate level and 1-year clinical outcomes in patients with
acute ischemic stroke and
transient ischemic attack. Methods: We included 7,353 patients with
acute ischemic stroke and
transient ischemic attack from the China National
Stroke Registry III for analysis. Participants were divided into 4 groups according to serum
phosphate quartiles. Composite end point included recurrent
stroke,
myocardial infarction, other ischemic vascular events, and all-cause mortality. Poor functional outcome is defined as modified Rankin Scale score of 3 to 6. Multivariable Cox regression or logistic regression was used to evaluate the independent association of serum
phosphate with 1-year all-cause mortality, recurrent
stroke, composite end point and poor functional outcome. Results: The mean age of the included 7,353 patients was 62.5 years, and 68.6% of them were men. Plotting hazard ratios over
phosphate levels suggested a U-shaped association especially for recurrent
stroke and composite end point, and therefore the third quartile group was set as reference group. Compared with the third quartile of
phosphate (1.06-1.20 mmol/L), the adjusted hazard ratios/odds ratios (95% CI) of the lowest quartile (<0.94 mmol/L) were 0.98 (0.67-1.42) for all-cause mortality, 1.31 (1.05-1.64) for
stroke recurrence, 1.26 (1.02-1.57) for composite end point, and 1.27 (1.01-1.61) for poor functional outcome, and the adjusted odds ratio of the highest quartile (≥1.2 mmol/L) was 1.40 (1.11-1.77) for poor functional outcome. Conclusions: Serum
phosphate may be an independent predictor of
stroke recurrence, composite end point and poor functional outcome after
ischemic stroke.